Physiologic variables affecting thromboxane B2 production in human whole blood
- 1 January 1985
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 37 (1) , 1-8
- https://doi.org/10.1016/0049-3848(85)90027-1
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Arachidonate metabolism in vascular disorders.Journal of Clinical Investigation, 1983
- Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.Journal of Clinical Investigation, 1983
- The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man.Circulation, 1983
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983
- THROMBOXANE A2 IN SKIN-BLEEDING-TIME BLOOD AND IN CLOTTED VENOUS BLOOD BEFORE AND AFTER ADMINISTRATION OF ACETYLSALICYLIC ACIDThe Lancet, 1983
- Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic PatientsNew England Journal of Medicine, 1983
- Reduced Platelet Thromboxane Formation in Uremia. EVIDENCE FOR A FUNCTIONAL CYCLOOXYGENASE DEFECTJournal of Clinical Investigation, 1983
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982
- DISTRIBUTION OF SOME RISK FACTORS FOR ATHEROSCLEROSIS IN NINE ITALIAN POPULATION SAMPLESAmerican Journal of Epidemiology, 1981
- Low dose aspirin and inhibition of thromboxane B2 production in healthy subjectsThrombosis Research, 1980